Kyoto Bio Pharma Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
About Kyoto Bio Pharma Llp
Kyoto Bio Pharma Llp (KBPL) is 8 Year, 3 Months old Limited Liability Partnership 04 October 2016. Its registered office is in Mumbai, Maharashtra, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2022 (FY 2021-2022). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN/FCRN
AAH-5346
-
Incorporation Date
04 Oct 2016
-
Date of Accounts and Solvency Statement
31 Mar 2022
-
ROC Code
Roc-Mumbai
-
Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Kyoto Bio Pharma Llp?
Designated Partners (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yugandhara Katkar
|
Designated Partner | 04-Oct-2016 | Current |
|
Rajnikant Annasaheb
|
Designated Partner | 04-Oct-2016 | Current |
|
Sunita Katkar
|
Designated Partner | 04-Oct-2016 | Current |
Financial Performance of Kyoto Bio Pharma Llp.
Enhance accessibility to Kyoto Bio Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kyoto Bio Pharma Llp?
Unlock access to Kyoto Bio Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Disha Auto Components Private LimitedSunita Katkar is a mutual person
-
Golden Eagle Cargo Tours & Travels LlpYugandhara Katkar and Sunita Katkar are mutual person
-
Kangaroo World Entertainment Llp
Yugandhara Katkar and Sunita Katkar are mutual person
-
Deccan Hospitality Services Llp
Rajnikant Annasaheb and Sunita Katkar are mutual person
-
Deccan Agro Research And Marketing Private Limited
Rajnikant Annasaheb and Sunita Katkar are mutual person
-
Amazon Consultancy Private Limited
Rajnikant Annasaheb and Sunita Katkar are mutual person
Charges (Loans)
There are no Open Charges registered against the LLP as per our records.
How Many Employees Work at Kyoto Bio Pharma Llp?
Unlock and access historical data on people associated with Kyoto Bio Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kyoto Bio Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kyoto Bio Pharma Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.